SonoScape Medical Corp
SZSE:300633

Watchlist Manager
SonoScape Medical Corp Logo
SonoScape Medical Corp
SZSE:300633
Watchlist
Price: 30.63 CNY -1.83% Market Closed
Market Cap: 13.3B CNY
Have any thoughts about
SonoScape Medical Corp?
Write Note

SonoScape Medical Corp
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SonoScape Medical Corp
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
SonoScape Medical Corp
SZSE:300633
Other Long-Term Assets
ÂĄ69.1m
CAGR 3-Years
6%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Other Long-Term Assets
ÂĄ61.5m
CAGR 3-Years
67%
CAGR 5-Years
116%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Other Long-Term Assets
ÂĄ263.2m
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
31%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Other Long-Term Assets
ÂĄ2.1B
CAGR 3-Years
-25%
CAGR 5-Years
22%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Other Long-Term Assets
ÂĄ122.6m
CAGR 3-Years
-26%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Other Long-Term Assets
ÂĄ541.5m
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

SonoScape Medical Corp
Glance View

Market Cap
13.2B CNY
Industry
Health Care

SonoScape Medical Corp, a company entrenched in the realm of medical technology, weaves its story around innovation and dedication in the healthcare sector. Founded in 2002, this Shenzhen-based company has become a global player in the development and production of medical equipment, particularly in the field of ultrasound and endoscopy. At its core, SonoScape melds cutting-edge technology with practical healthcare applications, aiming to improve diagnostic accuracy and patient outcomes. With its R&D centers rich in technical prowess and creativity, SonoScape continuously pushes forward the boundaries of medical imaging, offering a diverse range of ultrasound systems that cater to various clinical needs and environments. Revenue for SonoScape Medical Corp stems largely from the sale of these high-precision medical devices, which are marketed both domestically within China and internationally. The company thrives on the ever-growing demand for advanced healthcare solutions, ensuring a steady stream of income through its robust distribution channels across numerous countries. In addition to equipment sales, SonoScape provides comprehensive after-sales service packages, ensuring customer satisfaction and fostering long-term relationships with healthcare institutions. By maintaining a strong focus on innovation while meeting industry standards and regulations, SonoScape not only solidifies its financial standing but also enhances its reputation as a significant contributor to the global healthcare landscape.

Intrinsic Value
49.55 CNY
Undervaluation 38%
Intrinsic Value
Price

See Also

What is SonoScape Medical Corp's Other Long-Term Assets?
Other Long-Term Assets
69.1m CNY

Based on the financial report for Sep 30, 2024, SonoScape Medical Corp's Other Long-Term Assets amounts to 69.1m CNY.

What is SonoScape Medical Corp's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
-9%

Over the last year, the Other Long-Term Assets growth was -24%. The average annual Other Long-Term Assets growth rates for SonoScape Medical Corp have been 6% over the past three years , -9% over the past five years .

Back to Top